European Congress Of Immunology Research Articles

One year of Young EFIS: achievements and future directions

One year of Young EFIS: achievements and future directions

ACTERIA prizes to benefit more young researchers from 2020

ACTERIA prizes to benefit more young researchers from 2020

Already ENLIGHT‐TENed? Equipping young immunologists with a combination of research‐related and transferrable competencies

Already ENLIGHT‐TENed? Equipping young immunologists with a combination of research‐related and transferrable competencies

Women in Science Awards

Women in Science Awards

5th European Congress of Immunology (ECI 2018)–2‐5 September 2018 | Amsterdam, Netherlands

5^th European Congress of Immunology (ECI 2018)–2‐5 September 2018 | Amsterdam, Netherlands

European Congress of Immunology (ECI) 2018 – Amsterdam, The Netherlands

European Congress of Immunology (ECI) 2018 – Amsterdam, The Netherlands

4th European Congress of Immunology (ECI), September 6–9, 2015, Vienna, Austria

HLA-DRB1 gene variants are known risk factors for several immunological diseases. Patients with rheumatoid arthritis (RA) often carry HLA-DRB1*04 (DR4+), and have a repertoire of collagen IIp261-273specific T cells in the peripheral blood at the onset of the disease. Gabriele Di Sante (Rome, Italy) and colleagues enrolled 90 patients with early RA to determine whether this subset of DR4-restricted collagen-specific T cells could represent new markers of severity of the disease and response to therapy. The authors examined the usage of T-cell receptor (TCR)-beta chains in peripheral blood mononuclear cells cultured with or without the human collagen II peptide p261273. They found that the presence of T cells carrying TCR-beta chains TRBV25 and TRBV6_4was correlated toHLA-DR and RA disease activity, and the detection of TRBV25 T cells could predict active disease in DR4+ patients. HLA-DRB1*04/04, 04/01 and 04/11 alleles were significantly associated with TRBV25 usage, higher disease activity at RA onset, and poor response to disease-modifying anti-rheumatic drugs. The findings could help predict the course of RA and tailor treatments for RA patients.

4th European Congress of Immunology – ECI 2015

4^th European Congress of Immunology – ECI 2015

Spanish Immunology on the move

Spanish Immunology on the move

Prize winners in Bonn

Prize winners in Bonn

Arrivederci! EFIS activities at the 15th International Congress of Immunology 2013 in Milan

Arrivederci! EFIS activities at the 15^th International Congress of Immunology 2013 in Milan

Editorial

Editorial

The European Congress of Immunology: An international success thanks to its cooperative structure

The European Congress of Immunology: An international success thanks to its cooperative structure

Towards European synergism and entertaining the public

Towards European synergism and entertaining the public

2nd European Congress of Immunology

2nd European Congress of Immunology

Joining of forces between EJI and EFIS

Joining of forces between EJI and EFIS